Hos patienter behandlet for hæmatologiske maligne sygdomme begyndte B- celle regenerering inden for 6 måneders behandling og nåede normale niveauer mellem 9 og 12 måneder efter afsluttet behandling.
In patients treated for hematological malignancies, B cell repletion began within 6 months of treatment returning to normal levels between 9 and 12 months after completion of therapy.